Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study
HQ Team March 21, 2025: A study from China adds to mounting evidence that semaglutide—a medication widely used for type 2 diabetes (Ozempic).
Health
Drugs
Pharma
Breakthrough in halting dementia progression found by biotech company
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,.